Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering-Reference-Cited by-同舟云学术

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering

Published:2018-04-17 Issue:15 Volume:319 Page:1566
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Navarese Eliano P.¹²³,Robinson Jennifer G.⁴,Kowalewski Mariusz²⁵,Kolodziejczak Michalina²³,Andreotti Felicita²⁶,Bliden Kevin¹,Tantry Udaya¹,Kubica Jacek³,Raggi Paolo⁷,Gurbel Paul A.¹²

Affiliation:

1. Interventional Cardiology and Cardiovascular Medicine Research, Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, Virginia

2. Systematic Investigation and Research on Interventions and Outcomes (SIRIO) MEDICINE Cardiovascular Research Network

3. Cardiovascular Institute, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

4. Prevention Intervention Center, Departments of Epidemiology and Medicine, University of Iowa, Iowa City

5. Department of Cardiac Surgery, Cardiovascular Institute, Dr Antoni Jurasz Memorial University Hospital, Bydgoszcz, Poland

6. Institute of Cardiology, Catholic University Medical School, Rome, Italy

7. Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference46 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.;Baigent;Lancet,2010

2. Ezetimibe added to statin therapy after acute coronary syndromes.;Cannon;N Engl J Med,2015

3. Evolocumab and clinical outcomes in patients with cardiovascular disease.;Sabatine;N Engl J Med,2017

4. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.;Robinson;N Engl J Med,2015

5. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.;Sabatine;N Engl J Med,2015

Cited by 387 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry;Journal of Cardiology;2024-10

2. Statin therapy and cardiovascular protection in type 2 diabetes: The role of baseline LDL-Cholesterol levels. A systematic review and meta-analysis of observational studies;Nutrition, Metabolism and Cardiovascular Diseases;2024-09

3. Nogo-B inhibition facilitates cholesterol metabolism to reduce hypercholesterolemia;Cell Reports;2024-09

4. Serum IGFBP5 as a predictor of major adverse cardiac events in patients with acute myocardial infarction;International Journal of Cardiology;2024-09

5. Centralized and Federated Models for the Analysis of Clinical Data;Annual Review of Biomedical Data Science;2024-08-23